Romanian
Albanian
Arabic
Armenian
Azerbaijani
Belarusian
Bengali
Bosnian
Catalan
Czech
Danish
Deutsch
Dutch
English
Estonian
Finnish
Français
Greek
Haitian Creole
Hebrew
Hindi
Hungarian
Icelandic
Indonesian
Irish
Italian
Japanese
Korean
Latvian
Lithuanian
Macedonian
Mongolian
Norwegian
Persian
Polish
Portuguese
Romanian
Russian
Serbian
Slovak
Slovenian
Spanish
Swahili
Swedish
Turkish
Ukrainian
Vietnamese
Български
中文(简体)
中文(繁體)
pancreatitis/obezitate
Linkul este salvat în clipboard
Pagină 1 din 59 rezultate
Lipase inhibitors for the treatment of pancreatitis and organ failure
Numai utilizatorii înregistrați pot traduce articole
Log In / Înregistrare
1. INTRODUCTION
The present invention relates to the use of lipase inhibitors for the treatment of pancreatitis and/or organ failure.
2. BACKGROUND OF THE INVENTION
Obesity is a well documented risk factor for worse outcomes in acute pancreatitis (Martinez, et al., Pancreatology 2006, 6:206-209;
Lipase inhibitors for the treatment of pancreatitis and organ failure
Numai utilizatorii înregistrați pot traduce articole
Log In / Înregistrare
PRIORITY CLAIM
This application claims priority to U.S. Provisional Application No. 61/476,119, filed Apr. 15, 2011, the contents of which is hereby incorporated by reference in its entirety herein.
1. INTRODUCTION
The present invention relates to the use of lipase inhibitors for the treatment of
Methods and formulations for treating cardiovascular disease
Numai utilizatorii înregistrați pot traduce articole
Log In / Înregistrare
FIELD
The present invention relates to compositions and formulations comprising therapeutically or prophylactically active compounds or pharmaceutically acceptable salts thereof, methods for modulating the activity of Lyn kinase and methods for treating disorders associated with Lyn kinase. In
Methods and formulations for modulating Lyn kinase activity and treating related disorders
Numai utilizatorii înregistrați pot traduce articole
Log In / Înregistrare
FIELD
The present invention relates to compositions and formulations comprising therapeutically or prophylactically active compounds or pharmaceutically acceptable salts thereof, methods for modulating the activity of Lyn kinase and methods for treating disorders associated with Lyn kinase. In
Methods for modulating Lyn kinase activity and treating related disorders
Numai utilizatorii înregistrați pot traduce articole
Log In / Înregistrare
1. FIELD OF THE INVENTION
The present invention relates to compositions and formulations comprising therapeutically or prophylactically active compounds or pharmaceutically acceptable salts thereof, methods for modulating the activity of Lyn kinase and methods for treating disorders associated with
Methods and formulations for modulating Lyn kinase activity and treating related disorders
Numai utilizatorii înregistrați pot traduce articole
Log In / Înregistrare
FIELD
The present invention relates to compositions and formulations comprising therapeutically or prophylactically active compounds or pharmaceutically acceptable salts thereof, methods for modulating the activity of Lyn kinase and methods for treating disorders associated with Lyn kinase. In
Methods and formulations for modulating lyn kinase activity and treating related disorders
Numai utilizatorii înregistrați pot traduce articole
Log In / Înregistrare
1. FIELD OF THE INVENTION
The present invention relates to compositions and formulations comprising therapeutically or prophylactically active compounds or pharmaceutically acceptable salts thereof, methods for modulating the activity of Lyn kinase and methods for treating disorders associated with
Methods for modulating Lyn kinase activity and treating related disorders
Numai utilizatorii înregistrați pot traduce articole
Log In / Înregistrare
1. FIELD OF THE INVENTION
The present invention relates to compositions and formulations comprising therapeutically or prophylactically active compounds or pharmaceutically acceptable salts thereof, methods for modulating the activity of Lyn kinase and methods for treating disorders associated with
Nitrogen-containing bicyclic compounds and drugs containing the same as the active ingredient
Numai utilizatorii înregistrați pot traduce articole
Log In / Înregistrare
TECHNICAL FIELD
The present invention relates to a nitrogen-containing bicyclic compound or a pharmacologically acceptable salt thereof and a pharmaceutical composition comprising it as active ingredient.
More specifically, the present invention relates to (1) a compound of formula (I)
##STR00002##
MTP inhibiting aryl piperidines or piperazines substituted with 5-membered heterocycles
Numai utilizatorii înregistrați pot traduce articole
Log In / Înregistrare
The present invention is concerned with novel aryl piperidine or piperazine compounds substituted with certain 5-membered heterocycles having apoB secretion/MTP inhibiting activity and concomitant lipid lowering activity. The invention further relates to methods for preparing such compounds,
MTP inhibiting aryl piperydines or piperazines substituted with 5-membered heterocycles
Numai utilizatorii înregistrați pot traduce articole
Log In / Înregistrare
The present invention is concerned with novel aryl piperidine or piperazine compounds substituted with certain 5-membered heterocycles having apoB secretion/MTP inhibiting activity and concomitant lipid lowering activity. The invention further relates to methods for preparing such compounds,
Compound WS 727713
Numai utilizatorii înregistrați pot traduce articole
Log In / Înregistrare
TECHNICAL FIELD
The present invention relates to a new compound which is useful as a medicament or a cosmetic, to a process for producing the same and to a pharmaceutical composition comprising the same.
BACKGROUND ART
The melanocortin (MC) is a group of peptide hormones that are derived from
Herbal formulation for management of metabolic disorders and method of preparation thereof
Numai utilizatorii înregistrați pot traduce articole
Log In / Înregistrare
TECHNICAL FIELD
The embodiments disclosed in this specification relates to herbal formulation effective in the treatment, management and prevention of metabolic disorders, and more particularly in the treatment of dyslipidemia. It also relates to the process of preparation of such
Fatty acids and their use in conjugation to biomolecules
Numai utilizatorii înregistrați pot traduce articole
Log In / Înregistrare
FIELD OF THE INVENTION
The present invention relates to novel conjugates of GDF15 which have improved half-life and duration of action, method of making them and using them. The invention further relates to novel fatty acids and their use in extending the half-life of biomolecules via
3-piperidyl-4-oxoquinazoline derivatives and pharmaceutical compositions comprising the same
Numai utilizatorii înregistrați pot traduce articole
Log In / Înregistrare
TECHNICAL FIELD
This invention relates to a novel 3-piperidyl-4-oxoquinazoline derivative. More specifically, it relates to a pharmaceutical composition comprising a 3-piperidyl-4-oxoquinazoline derivative having microsomal triglyceride transfer protein (MTP)-inhibitory activity or its
Cea mai completă bază de date cu plante medicinale susținută de știință
- Funcționează în 55 de limbi
- Cure pe bază de plante susținute de știință
- Recunoașterea ierburilor după imagine
- Harta GPS interactivă - etichetați ierburile în locație (în curând)
- Citiți publicațiile științifice legate de căutarea dvs.
- Căutați plante medicinale după efectele lor
- Organizați-vă interesele și rămâneți la curent cu noutățile de cercetare, studiile clinice și brevetele
Tastați un simptom sau o boală și citiți despre plante care ar putea ajuta, tastați o plantă și vedeți boli și simptome împotriva cărora este folosit.
* Toate informațiile se bazează pe cercetări științifice publicate
